LIF and cholangiocarcinoma: We demonstrated that Mcl-1 expression is further augmented by LIF treatment in CCA cells, whilst the pro-apoptotic pBax expression remained unchanged, suggesting that this dysregulation could be a pivotal mechanism responsible for the resistance to apoptosis induced by LIF.